These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 27908292)

  • 21. Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations.
    Flanagan SE; Kapoor RR; Mali G; Cody D; Murphy N; Schwahn B; Siahanidou T; Banerjee I; Akcay T; Rubio-Cabezas O; Shield JP; Hussain K; Ellard S
    Eur J Endocrinol; 2010 May; 162(5):987-92. PubMed ID: 20164212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focal congenital hyperinsulinism managed by medical treatment: a diagnostic algorithm based on molecular genetic screening.
    Maiorana A; Barbetti F; Boiani A; Rufini V; Pizzoferro M; Francalanci P; Faletra F; Nichols CG; Grimaldi C; de Ville de Goyet J; Rahier J; Henquin JC; Dionisi-Vici C
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):679-88. PubMed ID: 24383515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Congenital hyperinsulinism in newborn and infant].
    Giurgea I; Ribeiro MJ; Boddaert N; Touati G; Robert JJ; Saudubray JM; Jaubert F; Bellanné-Chantelot C; Brunelle F; Nihoul-Fékété C; de Lonlay P
    Arch Pediatr; 2005 Nov; 12(11):1628-35. PubMed ID: 16198094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sirolimus in infants with congenital hyperinsulinism (CHI) - a single-centre experience.
    Panigrahy N; Chirla DK; Bagga N; Gunda RK; Sukhija B; Reddy L
    Eur J Pediatr; 2022 Jan; 181(1):407-412. PubMed ID: 34304300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and histological heterogeneity of congenital hyperinsulinism due to paternally inherited heterozygous ABCC8/KCNJ11 mutations.
    Arya VB; Guemes M; Nessa A; Alam S; Shah P; Gilbert C; Senniappan S; Flanagan SE; Ellard S; Hussain K
    Eur J Endocrinol; 2014 Dec; 171(6):685-95. PubMed ID: 25201519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The difficult management of persistent, non-focal congenital hyperinsulinism: A retrospective review from a single, tertiary center.
    Rasmussen AG; Melikian M; Globa E; Detlefsen S; Rasmussen L; Petersen H; Brusgaard K; Rasmussen AH; Mortensen MB; Christesen HT
    Pediatr Diabetes; 2020 May; 21(3):441-455. PubMed ID: 31997554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical presentation and treatment response to diazoxide in two siblings with congenital hyperinsulinism as a result of a novel compound heterozygous ABCC8 missense mutation.
    Galcheva S; Iotova V; Ellard S; Flanagan SE; Halvadzhiyan I; Petrova C; Hussain K
    J Pediatr Endocrinol Metab; 2017 Apr; 30(4):471-474. PubMed ID: 28328534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Octreotide-related exocrine pancreatic insufficiency (EPI) in congenital hyperinsulinism.
    Ros-Pérez P; Golmayo L; Cilleruelo ML; Gutiérrez C; Celaya P; Lacámara N; Martínez-Badás I; Güemes M; Argente J
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):947-950. PubMed ID: 32634108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoallelic ABCC8 mutations are a common cause of diazoxide-unresponsive diffuse form of congenital hyperinsulinism.
    Saint-Martin C; Zhou Q; Martin GM; Vaury C; Leroy G; Arnoux JB; de Lonlay P; Shyng SL; Bellanné-Chantelot C
    Clin Genet; 2015 May; 87(5):448-54. PubMed ID: 24814349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Newborn with Congenital Hyperinsulinism.
    Du Y; Ju R; Xi Y; Gou P
    Fetal Pediatr Pathol; 2019 Oct; 38(5):406-411. PubMed ID: 31002010
    [No Abstract]   [Full Text] [Related]  

  • 31. Congenital hyperinsulinism in Chinese patients: 5-yr treatment outcome of 95 clinical cases with genetic analysis of 55 cases.
    Gong C; Huang S; Su C; Qi Z; Liu F; Wu D; Cao B; Gu Y; Li W; Liang X; Liu M
    Pediatr Diabetes; 2016 May; 17(3):227-34. PubMed ID: 25639667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Characterization and Management of Congenital Hyperinsulinism: A Tertiary Centre Experience.
    Sharma R; Roy K; Satapathy AK; Kumar A; Nanda PM; Damle N; Houghton JAL; Flanagan SE; Radha V; Mohan V; Jain V
    Indian Pediatr; 2022 Feb; 59(2):105-109. PubMed ID: 34992182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperinsulinemic hypoglycemia evolving to gestational diabetes and diabetes mellitus in a family carrying the inactivating ABCC8 E1506K mutation.
    Vieira TC; Bergamin CS; Gurgel LC; Moisés RS
    Pediatr Diabetes; 2010 Nov; 11(7):505-8. PubMed ID: 20042013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Congenital hyperinsulinism in the north-east Netherlands. Clinical features and DNA diagnostics in 22 children].
    Verheul JC; Ris-Stalpers C; Bikker H; Bakker-van Waarde WM; Noordam C
    Ned Tijdschr Geneeskd; 2011; 155(32):A3343. PubMed ID: 21835061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and genetic characterization of congenital hyperinsulinism in Spain.
    Martínez R; Fernández-Ramos C; Vela A; Velayos T; Aguayo A; Urrutia I; Rica I; Castaño L;
    Eur J Endocrinol; 2016 Jun; 174(6):717-26. PubMed ID: 27188453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Partial diazoxide responsiveness in a neonate with hyperinsulinism due to homozygous ABCC8 mutation.
    Kiff S; Babb C; Guemes M; Dastamani A; Gilbert C; Flanagan SE; Ellard S; Barton J; Dattani M; Shah P
    Endocrinol Diabetes Metab Case Rep; 2019 Feb; 2019():. PubMed ID: 30753133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Could a combination of heterozygous ABCC8 and KCNJ11 mutations cause congenital hyperinsulinism?
    Rozenkova K; Nessa A; Obermannova B; Elblova L; Dusatkova P; Sumnik Z; Lebl J; Hussain K; Pruhova S
    J Pediatr Endocrinol Metab; 2017 Nov; 30(12):1311-1315. PubMed ID: 29127764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Dose-Titrated Glucagon Infusions in the Management of Congenital Hyperinsulinism: A Case Series.
    Salomon-Estebanez M; Yau D; Dunne MJ; Worth C; Birch S; Walewski JL; Banerjee I
    Front Endocrinol (Lausanne); 2020; 11():441. PubMed ID: 33013678
    [No Abstract]   [Full Text] [Related]  

  • 39. High Incidence of Heterozygous ABCC8 and HNF1A Mutations in Czech Patients With Congenital Hyperinsulinism.
    Rozenkova K; Malikova J; Nessa A; Dusatkova L; Bjørkhaug L; Obermannova B; Dusatkova P; Kytnarova J; Aukrust I; Najmi LA; Rypackova B; Sumnik Z; Lebl J; Njølstad PR; Hussain K; Pruhova S
    J Clin Endocrinol Metab; 2015 Dec; 100(12):E1540-9. PubMed ID: 26431509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A combination of nifedipine and octreotide treatment in an hyperinsulinemic hypoglycemic infant.
    Durmaz E; Flanagan SE; Parlak M; Ellard S; Akcurin S; Bircan I
    J Clin Res Pediatr Endocrinol; 2014; 6(2):119-21. PubMed ID: 24932607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.